Hrt Financial LP Cytosorbents Corp Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.86 - $4.03 $19,076 - $41,331	10,256 New	10,256 $19,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $108,920 - $151,087	-15,560 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $117,478 - $146,575	15,560 New	15,560 $117,000
Q1 2021 May 17, 2021	SELL	$8.23 - $11.48 $125,606 - $175,207	-15,262 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $116,754 - $137,052	15,262 New	15,262 $121,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.